查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1676986

心肺支持系統市場按組件、疾病類型、患者類型、應用和最終用途分類 - 2025 年至 2030 年全球預測

Cardiopulmonary Support System Market by Component, Disease Type, Patient Type, Application, End Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

心肺支援系統市場預計在 2024 年達到 26.5 億美元，2025 年達到 28.6 億美元，到 2030 年將達到 41.7 億美元，複合年成長率為 7.82%。

主要市場統計數據
基準年 2024 年 26.5億美元
預計 2025 年 28.6億美元
預測年份 2030 41.7億美元
複合年成長率（%） 7.82％

心肺支持系統是先進醫療技術與重症患者照護的交會點，為各種臨床挑戰提供維持生命的解決方案。在當今快速發展的醫療保健環境中，對複雜支援機制的需求比以往任何時候都更加迫切。本報告深入檢驗了由技術創新、人口變化和不斷變化的臨床需求所驅動的市場動態。全球格局的特點是注重患者結果和先進設備的整合，這些設備在外科手術、緊急干預和長期患者照護中發揮重要作用。

從歷史上看，心肺支持僅限於急性護理環境中的重症病例，但最近的技術突破已將其應用擴展到更常規的干涉措施，從而提高了康復率並縮短了重症患者的整體治療時間。這些發展不僅反映了臨床方法的改進，也反映了醫療保健重點向預防和全面護理的全面轉變。以病患安全和療效為核心，該市場持續展示強勁的投資和創新產品的推出，以重新定義臨床通訊協定，為相關人員提供全球機會和挑戰。

不斷變化的全球市場動態

由於技術進步和以患者為中心的護理新方法，心肺支持環境正在經歷重大變革時期。這一轉變的核心是數位健康工具和資料分析的日益融合，它們正在重塑治療通訊協定並最佳化重症加護設備的使用。最尖端科技的實施使得決策流程更快，提高了病患監測的精確度，並促進了更個人化的治療方法。

這些發展在很大程度上是由全球創新動力推動的，因為醫療保健提供者在效率需求和改善結果之間取得了平衡。這項轉型還將以增強設備互通性為標誌，確保無縫資料流和連續護理。此外，各地區監管機構已開始推出領先框架，鼓勵採用下一代輔助系統，增強市場競爭力。技術採用、監管支持和行業協作的整合為心肺護理的新時代奠定了基礎，其中效率的提高和患者結果的改善決定了卓越的標準。

更深入的細分洞察

研究市場區隔可以揭示出一幅具有多個方面的細微差別的圖景，影響產品開發、行銷策略和臨床應用。從組件角度來看，市場對心肺體外迴圈裝置、體外膜氧合系統、主動脈內球囊幫浦和心室輔助人工心臟等主要產品線進行了廣泛的分析。每個類別都有其獨特的特點，並經歷快速的技術創新，體現出效能指標和運作可靠性的提升。

此外，成人呼吸窘迫症候群、心源性休克和肺水腫等病症的研究進一步使疾病分類複雜化。這種分層凸顯了這些支持系統在管理各種情況中的重要性，而及時介入可以決定患者的治療結果。當考慮患者類型時，細分會變得更加深入，大致分為成人、老年人和兒童。老年患者尤其需要量身訂製的解決方案，因為他們的生理需求各不相同，這使得客製化設備功能變得更加重要。

基於應用的細分透過評估心臟外科手術、心臟病學、急診醫學和加護治療中的使用案例進一步細分市場。越來越多的醫療專業人士正在尋找能夠在各種醫療應用中提供多功能性和精確性的工具。最後，基於最終用途的審查顯示，門診手術中心、醫院和專科診所各自有不同的採購模式，並透過其獨特的購買行為和臨床要求推動需求。這種多方面的細分框架強調了在競爭日益激烈的市場中做出策略決策所需的洞察力的深度和廣度。

目錄

第 1 章 簡介

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 全球心肺疾病發生率不斷上升
      • 提高認知並增加獲得治療選擇的機會
      • 政府獎勵和資助鼓勵心肺支持技術創新
    • 限制因素
      • 心肺支持系統高成本
    • 機會
      • 擴大採用人工智慧來提高準確性和效率
      • 人們對可攜式、緊湊型心肺支持系統的興趣日益濃厚
    • 任務
      • 心肺支援設備的嚴格合規要求
  • 市場區隔分析
    • 組成部分：開胸手術中心肺體外迴圈的偏好增加
    • 應用：擴大心肺支持系統在心血管手術的應用
  • 波特五力分析
  • PESTEL 分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

6. 心肺支持系統市場（按組件）

  • 心肺機
  • 體外膜氧合
  • 主動脈內球囊泵
  • 輔助人工心臟

第7章。

  • 成人呼吸窘迫症候群
  • 心源性休克
  • 肺水腫

8. 心肺支持系統市場（依患者類型）

  • 成年患者
  • 老年病學
    • 病人
  • 兒科患者

第9章 心肺支持系統市場（按應用）

  • 心血管手術
  • 心臟病學
  • 緊急醫療
  • 加護治療

第 10 章。

  • 門診手術中心
  • 醫院
  • 專科門診

第 11 章美洲心肺支持系統市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

12. 亞太心肺支持系統市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

13. 歐洲、中東和非洲心肺支持系統市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章 競爭格局

  • 2024 年市場佔有率分析
  • FPNV 定位矩陣，2024 年
  • 競爭情境分析
  • 戰略分析與建議

公司列表

  • Abbott Laboratories
  • Baxter International
  • BIOTRONIK SE & Co KG
  • Boston Scientific Corporation
  • Concordia Laboratories Inc.
  • Edwards Lifesciences Corporation
  • Eurosets Srl
  • Fresenius Medical Care AG
  • General Electric Company
  • Getinge AB
  • Jarvik Heart, Inc.
  • Johnson & Johnson
  • LivaNova PLC
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • Penumbra, Inc.
  • Senko Medical Instrument Manufacturing Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens AG
  • Spectrum Medical
  • Stryker Corporation
  • SynCardia Systems, LLC
  • Terumo Corporation
Product Code: MRR-9E51C09046A2

The Cardiopulmonary Support System Market was valued at USD 2.65 billion in 2024 and is projected to grow to USD 2.86 billion in 2025, with a CAGR of 7.82%, reaching USD 4.17 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 2.65 billion
Estimated Year [2025] USD 2.86 billion
Forecast Year [2030] USD 4.17 billion
CAGR (%) 7.82%

The cardiopulmonary support system stands at the intersection of advanced medical technology and critical patient care, offering life-sustaining solutions to a diverse spectrum of clinical challenges. In today's rapidly evolving healthcare environment, the need for sophisticated support mechanisms is more pronounced than ever. This report provides an in-depth examination of the market dynamics, driven by innovation, demographic shifts, and evolving clinical demands. The global landscape is characterized by its emphasis on patient outcomes and the integration of advanced equipment, which together play a fundamental role in surgical procedures, emergency interventions, and long-term patient care.

Historically, cardiopulmonary support has been reserved for severe cases in acute care settings; however, recent technological breakthroughs have expanded its use into more routine interventions, thereby enhancing recovery rates and reducing the overall duration of critical care. These developments not only reflect improved clinical methodologies but also an overarching shift in healthcare priorities towards preventive and comprehensive care delivery. With patient safety and efficacy at its core, the market continues to witness robust investments and innovative product launches that are set to redefine clinical protocols, offering both opportunities and challenges for stakeholders globally.

Transformative Shifts in Global Market Dynamics

The landscape of cardiopulmonary support is undergoing profound transformative shifts, ignited by advancements in technology and a renewed commitment to patient-centric care. At the heart of this transformation is an increased integration of digital health tools and data analytics, which are reshaping treatment protocols and optimizing the use of critical care equipment. The infusion of cutting-edge technologies has enabled faster decision-making processes, higher precision in patient monitoring, and the facilitation of more personalized treatment regimens.

These developments have been largely driven by a global appetite for innovation, as healthcare providers navigate the dual demands of efficiency and improved outcomes. The transformative shifts are also characterized by the enhanced interoperability of devices, ensuring seamless data flow and continuity of care-a crucial component that supports risk management and optimal resource allocation. Adding to the momentum, regulatory bodies across various regions have begun to implement progressive frameworks that encourage the adoption of next-generation support systems, engendering greater market competitiveness. This confluence of technology adoption, regulatory support, and industry collaboration is setting the stage for a new era in cardiopulmonary care, where enhanced efficiency and better patient outcomes define the standard of excellence.

Deep Dive into Segmentation Insights

An exploration of market segmentation reveals a nuanced landscape with multiple dimensions that dictate product development, marketing strategies, and clinical applications. From a component perspective, the market is extensively analyzed across key product lines such as cardiopulmonary bypass equipment, extracorporeal membrane oxygenation systems, intra-aortic balloon pumps, and ventricular assist devices. Each category presents unique capabilities and is subject to rapid innovation, reflecting enhanced performance metrics and operational reliability.

Furthermore, disease type segmentation adds another layer of complexity, with studies examining conditions such as adult respiratory distress syndrome, cardiogenic shock, and pulmonary edema. This stratification highlights the critical nature of these support systems in managing diverse pathological conditions, where timely intervention can determine patient outcomes. The segmentation deepens further when patient type is considered, broadly categorized into adult, geriatric, and pediatric groups. With geriatric patients requiring particularly tailored solutions due to their distinct physiological needs, the focus on customized device functionalities becomes even more vital.

Application-based segmentation further delineates the market by assessing use cases in cardiac surgery, cardiology, emergency medicine, and intensive care. This contributes significant insights into the operational context and clinical efficacy of these systems, as practitioners increasingly demand tools that offer versatility and precision across various medical applications. Finally, a review based on end use reveals that ambulatory surgical centers, hospitals, and specialty clinics each possess distinct procurement patterns, channeling demand through unique purchasing behaviors and clinical requirements. This multifaceted segmentation framework underscores the depth and breadth of insights necessary to drive strategic decision-making in an increasingly competitive marketplace.

Based on Component, market is studied across Cardiopulmonary Bypass Equipment, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps, and Ventricular Assist Devices.

Based on Disease Type, market is studied across Adult Respiratory Distress Syndrome, Cardiogenic Shock, and Pulmonary Edema.

Based on Patient Type, market is studied across Adult Patients, Geriatric, and Pediatric Patients. The Geriatric is further studied across Patients.

Based on Application, market is studied across Cardiac Surgery, Cardiology, Emergency Medicine, and Intensive Care.

Based on End Use, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.

Intraregional Variances and Opportunities

The analysis of key regional insights highlights profound differences in market dynamics among major global territories. In the Americas, the market is propelled by advancements in healthcare infrastructure, strong investment in research and development, and an aggressive adoption of novel medical technologies that enhance clinical outcomes. This region benefits from robust regulatory support and a mature ecosystem that collectively contribute to rapid technological assimilation and widespread acceptance of cardiopulmonary support systems.

In contrast, the combined region of Europe, Middle East & Africa exhibits a unique blend of traditional clinical practices coupled with emergent innovation hubs. Here, deep-rooted clinical expertise exists alongside increasing integration of disruptive technologies, spurring growth in the adoption of hybrid systems that cater to both legacy and modern healthcare environments. This region remains sensitive to policy reforms and demographic shifts, ultimately influencing how technologies are integrated into everyday clinical practice.

The Asia-Pacific region is emerging as a dynamic and rapidly expanding market, driven by large-scale healthcare initiatives, increased capital investments, and an accelerating pace of technology adoption. Rising awareness and improving healthcare accessibility are contributing to a surge in demand for advanced clinical support products. The confluence of these factors positions the Asia-Pacific as a fertile ground for market expansion, where opportunities abound for innovative manufacturers and service providers.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The market is characterized by a competitive landscape populated by a diverse array of industry leaders and emerging players. Pioneering companies like Abbott Laboratories, Baxter International, and BIOTRONIK SE & Co KG have established robust portfolios that combine advanced technology with reliable performance. Likewise, prominent industry titans such as Boston Scientific Corporation and Edwards Lifesciences Corporation continue to drive innovation by investing significantly in research and development.

Other influential organizations including Concordia Laboratories Inc., Eurosets S.r.l, and Fresenius Medical Care AG have also contributed noteworthy advancements, leveraging their deep expertise in engineering and clinical research. Esteemed players like General Electric Company, Getinge AB, and Jarvik Heart, Inc. are well-regarded for their commitment to developing cutting-edge solutions that enhance the safety and efficiency of cardiopulmonary support systems. Strategic initiatives by Johnson & Johnson, LivaNova PLC, and Medtronic PLC have further reinforced the industry's trajectory towards smarter, more connected medical devices.

The competitive fabric is further enriched by organizations such as MicroPort Scientific Corporation, Nipro Corporation, and Penumbra, Inc., whose continuous innovations reflect a commitment to addressing nuanced clinical challenges. This competitive environment is complemented by offerings from Senko Medical Instrument Manufacturing Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens AG, Spectrum Medical, Stryker Corporation, SynCardia Systems, LLC, and Terumo Corporation, creating a robust portfolio that serves an extensively diverse patient base. The integration of vast clinical expertise, technological innovation, and strategic global partnerships has given rise to a market that continues to set new benchmarks in precision medicine and critical care solutions.

The report delves into recent significant developments in the Cardiopulmonary Support System Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Baxter International, BIOTRONIK SE & Co KG, Boston Scientific Corporation, Concordia Laboratories Inc., Edwards Lifesciences Corporation, Eurosets S.r.l, Fresenius Medical Care AG, General Electric Company, Getinge AB, Jarvik Heart, Inc., Johnson & Johnson, LivaNova PLC, Medtronic PLC, MicroPort Scientific Corporation, Nipro Corporation, Penumbra, Inc., Senko Medical Instrument Manufacturing Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens AG, Spectrum Medical, Stryker Corporation, SynCardia Systems, LLC, and Terumo Corporation. Strategic Recommendations for Market Leadership

Industry leaders are encouraged to capitalize on the rapid evolution of technology and the increasing demand for customized solutions in the cardiopulmonary support landscape. A key recommendation is to invest strategically in research and development initiatives that not only enhance current product lines but also explore emerging areas like artificial intelligence and real-time data analytics. Leveraging digital transformation can facilitate better integration of devices, providing a unified interface that enhances decision-making processes in complex clinical settings.

Moreover, building strategic alliances with academic institutions and research organizations can offer fresh perspectives and provide access to breakthrough technologies. Industry players should also focus on expanding their global footprint by tailoring solutions to meet local regulatory requirements, thereby fostering trust among healthcare providers. Continuous education and training programs for clinicians should be prioritized to ensure the proficient use of sophisticated support systems, ultimately driving improved patient outcomes.

A proactive approach towards understanding demographic trends and the shifting disease burden will prove essential. Leaders are advised to undertake comprehensive market research to pinpoint evolving patterns in patient types and disease conditions, ensuring timely alignment of product portfolios with growing clinical needs. Such a multifaceted strategy, grounded in innovation and collaboration, can drive sustained growth and secure a competitive edge in an increasingly complex and dynamic market environment.

Final Remarks and Strategic Outlook

In summary, the cardiopulmonary support system market is poised for unprecedented growth as advancements in technology and evolving clinical practices redefine the benchmarks of patient care. This report has detailed not only current market trends but also the multitude of segmentation insights that reveal deep structural changes within the industry. The shift towards integrated solutions and data-driven decision-making continues to provide avenues for enhanced safety, efficiency, and patient outcomes.

Looking ahead, it is evident that continued innovation, coupled with strategic collaborations, will serve as the cornerstone for future success. Stakeholders across the spectrum-from product developers and clinical researchers to healthcare providers and strategic investors-stand to benefit from embracing these advancements. This dynamic market landscape represents both challenges and significant opportunities for those poised to lead the charge in redefining critical care solutions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of cardiopulmonary diseases globally
      • 5.1.1.2. Rising awareness and accessibility of treatment options
      • 5.1.1.3. Government incentives and funding encouraging innovation in cardiopulmonary support technology
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of cardiopulmonary support systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing adoption of artificial intelligence in enhancing precision and efficiency
      • 5.1.3.2. Increasing preference for portable and compact cardiopulmonary support systems
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory compliance requirements for cardiopulmonary support devices
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Increasing preference for cardiopulmonary bypass equipment in open-heart surgeries
    • 5.2.2. Application: Expanding application of cardiopulmonary support systems in cardiac surgery
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiopulmonary Support System Market, by Component

  • 6.1. Introduction
  • 6.2. Cardiopulmonary Bypass Equipment
  • 6.3. Extracorporeal Membrane Oxygenation
  • 6.4. Intra-Aortic Balloon Pumps
  • 6.5. Ventricular Assist Devices

7. Cardiopulmonary Support System Market, by Disease Type

  • 7.1. Introduction
  • 7.2. Adult Respiratory Distress Syndrome
  • 7.3. Cardiogenic Shock
  • 7.4. Pulmonary Edema

8. Cardiopulmonary Support System Market, by Patient Type

  • 8.1. Introduction
  • 8.2. Adult Patients
  • 8.3. Geriatric
    • 8.3.1. Patients
  • 8.4. Pediatric Patients

9. Cardiopulmonary Support System Market, by Application

  • 9.1. Introduction
  • 9.2. Cardiac Surgery
  • 9.3. Cardiology
  • 9.4. Emergency Medicine
  • 9.5. Intensive Care

10. Cardiopulmonary Support System Market, by End Use

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Hospitals
  • 10.4. Specialty Clinics

11. Americas Cardiopulmonary Support System Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Cardiopulmonary Support System Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Cardiopulmonary Support System Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Corify Care's EUR 6 million funding amplifies non-invasive cardiac mapping innovation
    • 14.3.2. Medtronic innovates cardiopulmonary care with the launch of the user-friendly VitalFlow ECMO system
    • 14.3.3. NuvoAir and Privia Medical Group collaborate to enhance cardiopulmonary care with virtual-first model
    • 14.3.4. ADI launches FDA-approved Sensinel System for remote monitoring
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Baxter International
  • 3. BIOTRONIK SE & Co KG
  • 4. Boston Scientific Corporation
  • 5. Concordia Laboratories Inc.
  • 6. Edwards Lifesciences Corporation
  • 7. Eurosets S.r.l
  • 8. Fresenius Medical Care AG
  • 9. General Electric Company
  • 10. Getinge AB
  • 11. Jarvik Heart, Inc.
  • 12. Johnson & Johnson
  • 13. LivaNova PLC
  • 14. Medtronic PLC
  • 15. MicroPort Scientific Corporation
  • 16. Nipro Corporation
  • 17. Penumbra, Inc.
  • 18. Senko Medical Instrument Manufacturing Co., Ltd.
  • 19. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 20. Siemens AG
  • 21. Spectrum Medical
  • 22. Stryker Corporation
  • 23. SynCardia Systems, LLC
  • 24. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. CARDIOPULMONARY SUPPORT SYSTEM MARKET MULTI-CURRENCY
  • FIGURE 2. CARDIOPULMONARY SUPPORT SYSTEM MARKET MULTI-LANGUAGE
  • FIGURE 3. CARDIOPULMONARY SUPPORT SYSTEM MARKET RESEARCH PROCESS
  • FIGURE 4. CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. CARDIOPULMONARY SUPPORT SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. CARDIOPULMONARY SUPPORT SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CARDIOPULMONARY SUPPORT SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIOPULMONARY SUPPORT SYSTEM MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY INTRA-AORTIC BALLOON PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY ADULT RESPIRATORY DISTRESS SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY CARDIOGENIC SHOCK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PULMONARY EDEMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY ADULT PATIENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY EMERGENCY MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY INTENSIVE CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 281. CARDIOPULMONARY SUPPORT SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 282. CARDIOPULMONARY SUPPORT SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024